4 Topic Commentaries

Who Decides How AI Enters Pathology?

Who Decides How AI Enters Pathology?

• 

  Bakul Patel, MSEE, MBA

  Regulatory science (digital health and medical devices)

  •

  U.S. Food and Drug Administration

  This action plan outlines the FDA’s next steps towards furthering oversight for AI/ML-based SaMD,

  Source
• 

  Scott Gottlieb, MD

  Regulatory policy and medical devices

  •

  U.S. Food and Drug Administration

  Artificial intelligence and machine learning have the potential to fundamentally transform the delivery of health care.

  Source
• 

  Alexander S. Baras, MD, PhD

  Pathology informatics

  •

  Johns Hopkins Medicine

  It’s going to make us more efficient, it’s going to make us more accurate and it will eventually uncover new features of a disease.

  Source
• 

  James Zou, PhD

  Biomedical data science and AI in medicine

  •

  Stanford University School of Medicine

  We don't want a tool that replaces doctors, but something that collaborates well with doctors,

  Source